Kinney E, Goderwis D, Mullins R J, Larson G M
Department of Surgery, University of Louisville, School of Medicine, KY 40292.
Am Surg. 1988 Jan;54(1):15-8.
The purpose of this project was to evaluate the medical and surgical treatment of patients with recurrent peptic ulcer disease and to determine whether the addition of cimetidine has altered the treatment outcome. The authors studied 42 patients with recurrent ulcers after duodenal ulcer surgery. Four patients underwent emergency operation for ulcer-related complications, while 38 patients received medical therapy including cimetidine as initial treatment. Medical therapy achieved good results in 18 of 38 patients (47%). The remaining 20 patients either were treated surgically (14) or are still symptomatic. Four of the 18 patients managed operatively had a second recurrent ulcer (22%). There were no deaths. Thirty-two of the original 42 patients (76%) were helped by the treatment. It was concluded that cimetidine has improved medical therapy compared with historical controls but that operative treatment is indicated in about one-half of patients with recurrent peptic ulcer disease.
本项目的目的是评估复发性消化性溃疡疾病患者的内科及外科治疗情况,并确定添加西咪替丁是否改变了治疗结果。作者研究了42例十二指肠溃疡手术后复发性溃疡的患者。4例患者因溃疡相关并发症接受了急诊手术,而38例患者接受了包括西咪替丁在内的内科治疗作为初始治疗。内科治疗在38例患者中的18例(47%)取得了良好效果。其余20例患者要么接受了手术治疗(14例),要么仍有症状。接受手术治疗的18例患者中有4例出现了第二次复发性溃疡(22%)。无死亡病例。最初的42例患者中有32例(76%)通过治疗得到了帮助。得出的结论是,与历史对照相比,西咪替丁改善了内科治疗,但约一半的复发性消化性溃疡疾病患者仍需手术治疗。